Institutional Biosafety Committee – Vaccinia

Layout for printing

Policy Number:

UW-6083

Old Policy Number:

IBC-POL-013

Responsible Office:

Environment, Health and Safety

University Policy

Rationale/​Purpose:

The purpose of this Institutional Biosafety Committee (IBC) policy is to ensure that researchers working with vaccinia virus receive information about vaccinia vaccination and complete the lab specific occupational health plan for vaccinia.

 

Scope:

This policy applies to all members of the UW–Madison IBC, UW–Madison Office of Biological Safety (OBS), UW–Madison Principal Investigators (PI), and UW–Madison employees and staff, along with any additional personnel listed on the biosafety protocol, as applicable.

Policy:

This policy requires PIs who conduct activities with vaccinia virus to complete a Lab Specific Occupational Health Plan for Vaccinia and to direct any employees that will be working with vaccinia under their biosafety protocol to fill out the form. All laboratory employees working with vaccinia will receive an evaluation from UW-Madison Occupational Medicine. The laboratory PI is responsible for maintaining the signed record for all personnel working with vaccinia. 

Related UW–Madison Documents, Web Pages, or Other Resources:

Lab Specific Occupational Health Plan for Vaccinia template

Monkeypox Exposure Medical Response Guidance for the University of Wisconsin- Madison (OH-GUI-043)

UW–Madison, Occupational Health Program, Document Control System, Vaccinia Exposure Medical Response Guidance for the University of Wisconsin–Madison, current version

The UW–Madison Researchers’ Biosafety Manual (Office of Biological Safety website)

External References:

U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), Emergency Preparedness and Response website, Smallpox

U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) - Biosafety in Microbiological and Biomedical Laboratories (BMBL), current version

U.S Department of Health and Human Services, National Institutes of Health (NIH) - NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, current version

Virology, Risks Associated with Vaccinia in the Laboratory, Science Direct, Volume 385, Issue 1, 1 March 2009, Pages 1–4

Policy Administration

Approval Authority:

Institutional Biosafety Committee

Policy Manager:

Director of Biological Safety - Biological Safety Officer

Contact:

Director of Biological Safety - Biological Safety Officer -- Andrea Ladd, andrea.ladd@wisc.edu, (608) 263-9013
Associate Biological Safety Officer -- Stephanie Kutz, stephanie.kutz@wisc.edu, (608) 622-9764

Effective Date:

06-05-2013

Date Issued:

06-05-2013

Revised Dates:

04-06-2022

Retrieved:

09-29-2023 16:51:08